missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Rabies Virus Nucleoprotein Antibody (02) - (CVS-11), Novus Biologicals™
  7. 30159875

Rabies Virus Nucleoprotein Antibody (02) - (CVS-11), Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals (Bio-Techne) NBP3-33165-100ul

 View more versions of this product

Product Code. 30159875

  • 387.00 € / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Rabies Virus Nucleoprotein Monoclonal antibody specifically detects Rabies Virus Nucleoprotein in Virus samples. It is validated for ELISA,Sandwich ELISA Capture
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Rabies Virus Nucleoprotein
Monoclonal
Unconjugated
0.2 um filtered solution in PBS
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Rabies Virus Nucleoprotein (Uniprot#: Q8JXF6; Met1-Ser450).
100 μL
Primary
Store at 4°C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
IgG2b
ELISA, Sandwich ELISA Capture
02
ELISA 1:1000-1:2000, Sandwich ELISA Capture 1:250-1:2000
Mouse
Protein A purified
RUO
Virus
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.